Acknowledging the kind of traction gained by this market, recently published a study report asserts the global Gelatin-Based Plasma Expander Market size is projected to accrue voluminously by 2029 registering a phenomenal CAGR of 3.5 % during the review period (2022 to 2029).
Gelatin-Based Plasma Expander Market Overview
Plasma expander, also known as plasma compatibilizer, is a plasma substitute. The global market for gelatin polypeptide plasma volume enhancers is highly concentrated. Plasma expanders are currently available in two types: colloid and crystalloid. It can be used as an alternative to dextran, albumin, and other colloidal expanders
On a daily basis, volume expanders are utilised widely in orthopaedic, hepatic, and vascular procedures. It's also employed in the event of a medical emergency or a life-threatening incident involving blood loss. According to the Centers for Disease Control and Prevention (CDC), 35 million injury-related emergency care patients were admitted in the United States in 2018. As a result, demand for plasma expanders is increasing, and the market is growing.
The therapeutic application of gelatin plasma expanders for hypovolemic shocks and other disorders involving blood loss is limited due to the large amount of endotoxin. However, major efforts are being undertaken to lower endotoxin levels in gelatin, the foundation ingredient. These efforts have the potential to propel the market to new heights. A significant market driver has been the expanding usage of plasma expanders. Gelofusine and Haemaccel, two new generation gelatin expanders, are commonly used in the United Kingdom. Gelatin-based products were the most regularly utilised colloid (1.7 percent of all fluid administrations), followed by starch or starch-based products (0.2 percent), and albumin (0.1 percent), according to the Royal College of Anesthetists' 6th National Audit Project (NAP6) (0.1 percent). All NHS hospitals were invited to participate in NAP6.
What is our Gelatin-Based Plasma Expander Market report scope?
Report Attributes
|
Report Details
|
Forecast Period 2022 to 2029 CAGR
|
CAGR of 3.5% during the review period (2022 to 2029).
|
By Type
|
- Content of 4.0%
- Content of 3.5%
- Content of 3.2%
|
By Application
|
- Preoperative Prevention
- Cardiopulmonary Bypass and Dialysis
|
By Companies
|
Braun, Abbott, Wuhan Hualong Biological Pharmaceutical Co.,Ltd., Zhejiang Kangle Pharmaceutical Co.,Ltd., China BBCA Group Corporation, Harbin Sanctity Biological Pharmaceutical, Fuzhou Neptunus Futao Pharmaceuticals Co.,Ltd., Dikang, WUHAN DOCAN PHARMACEUTICAL CO.LTD
|
Regions Covered
|
- North America
- Europe
- Asia-Pacific
- Rest of the World
|
Countries Covered
|
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
|
Base Year
|
2022
|
Historical Year
|
2017 to 2021
|
Forecast Year
|
2022 to 2029
|
Number of Pages
|
161
|
Customization Available
|
Yes, the report can be customized as per your needs
|
Who are the Major Players in Gelatin-Based Plasma Expander Market?
The Gelatin-Based Plasma Expander Market is growing at a very fast pace and has seen the focus of many local and regional vendors offering precise application products for multiple end users. The three dependencies for the status of major companies in the market are: company profile, profitable gross margin, the prices they charge. These are the main players in this Braun, Abbott (NYSE: ABT), Wuhan Hualong Biological Pharmaceutical Co.,Ltd., Zhejiang Kangle Pharmaceutical Co.,Ltd., China BBCA Group Corporation, Harbin Sanctity Biological Pharmaceutical, Fuzhou Neptunus Futao Pharmaceuticals Co.,Ltd., Dikang, WUHAN DOCAN PHARMACEUTICAL CO.LTD, Piramal Pharma Limited’s (PPL) and others.
Industry News:
March 31, 2021: Piramal Pharma Limited’s (PPL) Contract Development and Manufacturing Organization (CDMO), Piramal Pharma Solutions (PPS), announced that PPL has entered into an agreement to obtain a 100% stake in Hemmo Pharmaceuticals Pvt Ltd. (Hemmo) for an upfront consideration of INR 775 crores and earn-outs linked to achievement of milestones.
What are the major Applications, Types and Regions for Gelatin-Based Plasma Expander Market?
By Type, it is segmented into
- Content of 4.0%
- Content of 3.5%
- Content of 3.2%
By Applications it is segmented into
- Preoperative Prevention
- Cardiopulmonary Bypass and Dialysis
Gelatin-Based Plasma Expander Market Regional Analysis
The market is dominated by North America. Blood disorders, blood loss, hypovolemia, pancreatitis, and trauma are all treated with an intravenous volume expander. People who have been in a serious accident can benefit from this treatment. In North America, the number of traffic accidents is rising at an alarming rate, with many of these occurrences being caused by drunk driving.
The market for Gelatin-Based Plasma Expander in Asia is predicted to increase rapidly over the next few years, followed by Europe. In Asia, China and India are likely to be the fastest expanding markets.
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Middle East & Africa
- Latin America
The Gelatin-Based Plasma Expander Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Gelatin-Based Plasma Expander Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Key Insights
- Pricing Analysis, By Key Regions, 2022
- Price Comparison (USD Per Ton) By Type (Content of 4.0%, Content of 3.5%, Content of 3.2%) 2021/2022
- Price Comparison (USD, Per Ton): By Application (Preoperative Prevention, Cardiopulmonary Bypass and Dialysis) 2021/2022
- Impact of COVID-19 on the Gelatin-Based Plasma Expander Market
- Production Share of Gelatin-Based Plasma Expander, By Region, 2022
- Key Industry Developments
- Global Gelatin-Based Plasma Expander Market Analysis, Insights and Forecast, 2022-2029
- Market Analysis, Insights and Forecast – By Application
- Preoperative Prevention
- Cardiopulmonary Bypass and Dialysis
- Market Analysis, Insights and Forecast – By Type
- Content of 4.0%
- Content of 3.5%
- Content of 3.2%
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Rest of World
- Competitive Analysis
- Global Market Share Analysis (2021)
- Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
- Braun
- Overview,
- Products,
- SWOT analysis,
- Recent developments,
- strategies,
- financials (based on availability)
- Abbott
- Overview,
- Products,
- SWOT analysis,
- Recent developments,
- strategies,
- financials (based on availability)
- Wuhan Hualong Biological Pharmaceutical Co
- Overview,
- Products,
- SWOT analysis,
- Recent developments,
- strategies,
- financials (based on availability)
- Zhejiang Kangle Pharmaceutical Co
- Overview,
- Products,
- SWOT analysis,
- Recent developments,
- strategies,
- financials (based on availability)
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.